AngioDynamics, Inc. (ANGO) vs Aquestive Therapeutics, Inc. (AQST)
A side-by-side comparison of AngioDynamics, Inc. and Aquestive Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANGO
AngioDynamics, Inc.
$14.38HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
AQST
Aquestive Therapeutics, Inc.
$4.61HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
Total return — ANGO vs AQST
growth of $100 · dividends reinvested · last 8yANGO -27.7% (-4.0%/yr)AQST -71.5% (-14.5%/yr)ANGO compounded faster over this window
ANGO AQST
ANGO vs AQST: by the numbers
- •ANGO is the larger company ($594M vs $578M market cap).
- •Both run net losses; ANGO's is the smaller (-11.48% vs -144.63% net margin).
- •ANGO grew revenue faster over the past five years (1.93% vs -0.58% CAGR).
Metrics side by side
Valuation
| Metric | ANGO | AQST |
|---|---|---|
| P/S ratio | 1.86 | 10.68 |
| P/B ratio | 3.48 | N/A |
| FCF yield | 0.09% | N/A |
Profitability
| Metric | ANGO | AQST |
|---|---|---|
| Gross margin | 54.62% | 67.04% |
| Operating margin | -12.47% | -156.36% |
| Net margin | -11.48% | -144.63% |
| ROE | -21.51% | N/A |
| ROIC | -20.75% | -45.62% |
Growth (annualized)
| Metric | ANGO | AQST |
|---|---|---|
| Revenue CAGR (5Y) | 1.93% | -0.58% |
| FCF CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -10.80% | 2.24% |
Frequently asked
- Which has grown faster, ANGO or AQST?
- Over the past five years, ANGO grew revenue faster — ANGO at a 1.93% CAGR versus AQST at -0.58%.
- How have ANGO and AQST total returns compared?
- Over the past 5 years, ANGO delivered -10.80% and AQST delivered 2.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.